Back to Report Store Home

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018

  • Published: Sep-2018
  • Report Code: GBIHC045IDB
  • Report Format: pdf

Description

List of Figures

Figure 1: Number of Products under Development for Post-Traumatic Stress Disorder (PTSD)

Figure 2: Number of Products under Development by Companies, Post-Traumatic Stress Disorder (PTSD)

Figure 3: Number of Products under Development by Universities/Institutes, Post-Traumatic Stress Disorder (PTSD)

Figure 4: Number of Products under Development for Obsessive-Compulsive Disorder

Figure 5: Number of Products under Development by Companies, Obsessive-Compulsive Disorder

Figure 6: Number of Products under Development for Depression

Figure 7: Number of Products under Development by Companies, Depression

Figure 8: Number of Products under Development by Universities/Institutes, Depression

Figure 9: Number of Products by Top 10 Targets, Post-Traumatic Stress Disorder (PTSD)

Figure 10: Number of Products by Stage and Top 10 Targets, Post-Traumatic Stress Disorder (PTSD)

Figure 11: Number of Products by Top 10 Mechanism of Actions, Post-Traumatic Stress Disorder (PTSD)

Figure 12: Number of Products by Stage and Top 10 Mechanism of Actions, Post-Traumatic Stress Disorder (PTSD)

Figure 13: Number of Products by Routes of Administration, Post-Traumatic Stress Disorder (PTSD)

Figure 14: Number of Products by Stage and Routes of Administration, Post-Traumatic Stress Disorder (PTSD)

Figure 15: Number of Products by Molecule Types, Post-Traumatic Stress Disorder (PTSD)

Figure 16: Number of Products by Stage and Molecule Types, Post-Traumatic Stress Disorder (PTSD)

Figure 17: Number of Products by Top 10 Targets, Obsessive-Compulsive Disorder

Figure 18: Number of Products by Stage and Top 10 Targets, Obsessive-Compulsive Disorder

Figure 19: Number of Products by Top 10 Mechanism of Actions, Obsessive-Compulsive Disorder

Figure 20: Number of Products by Stage and Top 10 Mechanism of Actions, Obsessive-Compulsive Disorder

Figure 21: Number of Products by Stage and Routes of Administration, Obsessive-Compulsive Disorder

Figure 22: Number of Products by Stage and Top 10 Molecule Types, Obsessive-Compulsive Disorder

Figure 23: Number of Products by Top 10 Targets, Depression

Figure 24: Number of Products by Stage and Top 10 Targets, Depression

Figure 25: Number of Products by Top 10 Mechanism of Actions, Depression

Figure 26: Number of Products by Stage and Top 10 Mechanism of Actions, Depression

Figure 27: Number of Products by Routes of Administration, Depression

Figure 28: Number of Products by Stage and Routes of Administration, Depression

Figure 29: Number of Products by Molecule Types, Depression

Figure 30: Number of Products by Stage and Molecule Types, Depression

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards